PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3028% below fair value
$16.94+1.18 (+7.49%)
Close on Nov 18, 2026Market cap $2.35BP/E –Yield 6.85%
Perrigo free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Perrigo's free cash flow for the twelve months ending Jun 27, 2026 was $119.30M, down 53.5% year over year. For fiscal 2025 it was $145.10M, down 40.7% from the year before. Over ten years it grew -10.9% a year on average. The highest annual figure on record is $718.20M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $145.10M | -40.7% |
| FY2024 | Dec 31, 2024 | $244.60M | -19.5% |
| FY2023 | Dec 31, 2023 | $303.80M | +44.0% |
| FY2022 | Dec 31, 2022 | $210.90M | +4921.4% |
| FY2021 | Dec 31, 2021 | $4.20M | -99.1% |
| FY2020 | Dec 31, 2020 | $465.80M | +86.2% |
| FY2019 | Dec 31, 2019 | $250.10M | -49.0% |
| FY2018 | Dec 31, 2018 | $490.40M | -19.6% |
| FY2017 | Dec 31, 2017 | $610.30M | -15.0% |
| FY2015 | Jun 27, 2015 | $718.20M | +55.7% |
| FY2014 | Jun 28, 2014 | $461.40M | +2.6% |
| FY2013 | Jun 29, 2013 | $449.70M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 27, 2026 | $68.30M | +20.5% |
| Q1 FY2026CQ1 2026 | Mar 28, 2026 | -$127.40M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $148.60M | -45.9% |
| Q3 FY2025CQ3 2025 | Sep 27, 2025 | $29.80M | +97.4% |
| Q2 FY2025CQ2 2025 | Jun 28, 2025 | $56.70M | – |
| Q1 FY2025CQ1 2025 | Mar 29, 2025 | -$90.00M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $274.90M | +51.0% |
| Q3 FY2024CQ3 2024 | Sep 28, 2024 | $15.10M | -83.7% |
| Q2 FY2024CQ2 2024 | Jun 29, 2024 | -$18.90M | -157.4% |
| Q1 FY2024CQ1 2024 | Mar 30, 2024 | -$26.50M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $182.00M | +14.1% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $92.70M | +144.6% |
| Q2 FY2023CQ2 2023 | Jul 1, 2023 | $32.90M | – |
| Q1 FY2023CQ1 2023 | Apr 1, 2023 | -$3.80M | -106.5% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $159.50M | – |
| Q3 FY2022CQ3 2022 | Oct 1, 2022 | $37.90M | -87.4% |
| Q2 FY2022CQ2 2022 | Jul 2, 2022 | -$45.30M | – |
| Q1 FY2022CQ1 2022 | Apr 2, 2022 | $58.80M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$147.10M | -432.1% |
| Q3 FY2021CQ3 2021 | Oct 2, 2021 | $301.80M | +1496.8% |
| Q2 FY2021CQ2 2021 | Jul 3, 2021 | -$105.30M | -139.8% |
| Q1 FY2021CQ1 2021 | Apr 3, 2021 | -$45.20M | -132.8% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $44.30M | +5.2% |
| Q3 FY2020CQ3 2020 | Sep 26, 2020 | $18.90M | -81.9% |
| Q2 FY2020CQ2 2020 | Jun 27, 2020 | $264.60M | +776.2% |
| Q1 FY2020CQ1 2020 | Mar 28, 2020 | $138.00M | +88.0% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $42.10M | -71.6% |
| Q3 FY2019CQ3 2019 | Sep 28, 2019 | $104.40M | -13.4% |
| Q2 FY2019CQ2 2019 | Jun 29, 2019 | $30.20M | -51.6% |
| Q1 FY2019CQ1 2019 | Mar 30, 2019 | $73.40M | -53.8% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $148.50M | -19.1% |
| Q3 FY2018CQ3 2018 | Sep 29, 2018 | $120.50M | -32.6% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $62.40M | -17.5% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $159.00M | -7.8% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $183.50M | +194.1% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $178.70M | +20.5% |
| Q2 FY2017CQ2 2017 | Jul 1, 2017 | $75.60M | – |
| Q1 FY2017CQ1 2017 | Apr 1, 2017 | $172.50M | – |
| Q4 FY2015CQ2 2015 | Jun 27, 2015 | $62.40M | – |
| Q3 FY2015CQ1 2015 | Mar 28, 2015 | $148.30M | – |
See a number that looks wrong?